Teva and J&J settle Ortho Tri-Cyclen Lo litigation
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industries has agreed to settle an ongoing patent infringement lawsuit with Johnson & Johnson over Teva's generic version of J&J's Ortho Tri-Cyclen Lo (norgestimate plus ethinylestradiol).